394 related articles for article (PubMed ID: 33215740)
21. IFN-γ or IFN-α ameliorates chronic proliferative dermatitis by inducing expression of linear ubiquitin chain assembly complex.
Tamiya H; Terao M; Takiuchi T; Nakahara M; Sasaki Y; Katayama I; Yoshikawa H; Iwai K
J Immunol; 2014 Apr; 192(8):3793-804. PubMed ID: 24634492
[TBL] [Abstract][Full Text] [Related]
22. Suppression of LUBAC-mediated linear ubiquitination by a specific interaction between LUBAC and the deubiquitinases CYLD and OTULIN.
Takiuchi T; Nakagawa T; Tamiya H; Fujita H; Sasaki Y; Saeki Y; Takeda H; Sawasaki T; Buchberger A; Kimura T; Iwai K
Genes Cells; 2014 Mar; 19(3):254-72. PubMed ID: 24461064
[TBL] [Abstract][Full Text] [Related]
23. The Linear ubiquitin chain assembly complex acts as a liver tumor suppressor and inhibits hepatocyte apoptosis and hepatitis.
Shimizu Y; Peltzer N; Sevko A; Lafont E; Sarr A; Draberova H; Walczak H
Hepatology; 2017 Jun; 65(6):1963-1978. PubMed ID: 28120397
[TBL] [Abstract][Full Text] [Related]
24. Biophysical and biological evaluation of optimized stapled peptide inhibitors of the linear ubiquitin chain assembly complex (LUBAC).
Aguilar-Alonso F; Whiting AL; Kim YJ; Bernal F
Bioorg Med Chem; 2018 Mar; 26(6):1179-1188. PubMed ID: 29246782
[TBL] [Abstract][Full Text] [Related]
25. Cellular and Mathematical Analyses of LUBAC Involvement in T Cell Receptor-Mediated NF-κB Activation Pathway.
Oikawa D; Hatanaka N; Suzuki T; Tokunaga F
Front Immunol; 2020; 11():601926. PubMed ID: 33329596
[TBL] [Abstract][Full Text] [Related]
26. Second Case of HOIP Deficiency Expands Clinical Features and Defines Inflammatory Transcriptome Regulated by LUBAC.
Oda H; Beck DB; Kuehn HS; Sampaio Moura N; Hoffmann P; Ibarra M; Stoddard J; Tsai WL; Gutierrez-Cruz G; Gadina M; Rosenzweig SD; Kastner DL; Notarangelo LD; Aksentijevich I
Front Immunol; 2019; 10():479. PubMed ID: 30936877
[No Abstract] [Full Text] [Related]
27. LUBAC accelerates B-cell lymphomagenesis by conferring resistance to genotoxic stress on B cells.
Jo T; Nishikori M; Kogure Y; Arima H; Sasaki K; Sasaki Y; Nakagawa T; Iwai F; Momose S; Shiraishi A; Kiyonari H; Kagaya N; Onuki T; Shin-Ya K; Yoshida M; Kataoka K; Ogawa S; Iwai K; Takaori-Kondo A
Blood; 2020 Aug; 136(6):684-697. PubMed ID: 32325488
[TBL] [Abstract][Full Text] [Related]
28. Biochemistry, Pathophysiology, and Regulation of Linear Ubiquitination: Intricate Regulation by Coordinated Functions of the Associated Ligase and Deubiquitinase.
Fuseya Y; Iwai K
Cells; 2021 Oct; 10(10):. PubMed ID: 34685685
[TBL] [Abstract][Full Text] [Related]
29. Shigella flexneri suppresses NF-κB activation by inhibiting linear ubiquitin chain ligation.
de Jong MF; Liu Z; Chen D; Alto NM
Nat Microbiol; 2016 May; 1(7):16084. PubMed ID: 27572974
[TBL] [Abstract][Full Text] [Related]
30. The LUBAC participates in lysophosphatidic acid-induced NF-κB activation.
Douanne T; Chapelier S; Rottapel R; Gavard J; Bidère N
Cell Immunol; 2020 Jul; 353():104133. PubMed ID: 32450431
[TBL] [Abstract][Full Text] [Related]
31. SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex.
Tokunaga F; Nakagawa T; Nakahara M; Saeki Y; Taniguchi M; Sakata S; Tanaka K; Nakano H; Iwai K
Nature; 2011 Mar; 471(7340):633-6. PubMed ID: 21455180
[TBL] [Abstract][Full Text] [Related]
32. The fructose-2,6-bisphosphatase TIGAR suppresses NF-κB signaling by directly inhibiting the linear ubiquitin assembly complex LUBAC.
Tang Y; Kwon H; Neel BA; Kasher-Meron M; Pessin JB; Yamada E; Pessin JE
J Biol Chem; 2018 May; 293(20):7578-7591. PubMed ID: 29650758
[TBL] [Abstract][Full Text] [Related]
33. Genetic deletion and pharmacologic inhibition of E3 ubiquitin ligase HOIP impairs the propagation of myeloid leukemia.
Jimbo K; Hattori A; Koide S; Ito T; Sasaki K; Iwai K; Nannya Y; Iwama A; Tojo A; Konuma T
Leukemia; 2023 Jan; 37(1):122-133. PubMed ID: 36352193
[TBL] [Abstract][Full Text] [Related]
34. Cross-regulation between LUBAC and caspase-1 modulates cell death and inflammation.
Douglas T; Saleh M
J Biol Chem; 2020 Apr; 295(16):5216-5228. PubMed ID: 32122970
[TBL] [Abstract][Full Text] [Related]
35. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction.
Haas TL; Emmerich CH; Gerlach B; Schmukle AC; Cordier SM; Rieser E; Feltham R; Vince J; Warnken U; Wenger T; Koschny R; Komander D; Silke J; Walczak H
Mol Cell; 2009 Dec; 36(5):831-44. PubMed ID: 20005846
[TBL] [Abstract][Full Text] [Related]
36. Structural Insights into SHARPIN-Mediated Activation of HOIP for the Linear Ubiquitin Chain Assembly.
Liu J; Wang Y; Gong Y; Fu T; Hu S; Zhou Z; Pan L
Cell Rep; 2017 Oct; 21(1):27-36. PubMed ID: 28978479
[TBL] [Abstract][Full Text] [Related]
37. Linear Ubiquitin Code: Its Writer, Erasers, Decoders, Inhibitors, and Implications in Disorders.
Oikawa D; Sato Y; Ito H; Tokunaga F
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403254
[TBL] [Abstract][Full Text] [Related]
38. LUBAC and OTULIN regulate autophagy initiation and maturation by mediating the linear ubiquitination and the stabilization of ATG13.
Chu Y; Kang Y; Yan C; Yang C; Zhang T; Huo H; Liu Y
Autophagy; 2021 Jul; 17(7):1684-1699. PubMed ID: 32543267
[TBL] [Abstract][Full Text] [Related]
39. Linear ubiquitination prevents inflammation and regulates immune signalling.
Gerlach B; Cordier SM; Schmukle AC; Emmerich CH; Rieser E; Haas TL; Webb AI; Rickard JA; Anderton H; Wong WW; Nachbur U; Gangoda L; Warnken U; Purcell AW; Silke J; Walczak H
Nature; 2011 Mar; 471(7340):591-6. PubMed ID: 21455173
[TBL] [Abstract][Full Text] [Related]
40. Structural basis for the simultaneous recognition of NEMO and acceptor ubiquitin by the HOIP NZF1 domain.
Rahighi S; Iyer M; Oveisi H; Nasser S; Duong V
Sci Rep; 2022 Jul; 12(1):12241. PubMed ID: 35851409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
